News About: Pharm. Industry
Kolon Life Science to go public
Kolon Life Science, Inc. (KLS), a subsidiary company of Kolon Group, is in the process of stepping into the secondary stock market Kosdaq.
The company is scheduled to sell 720,000 shares in its public offerings to ...
Green Cross to seek re-approval over human placenta injection
Green Cross Corporation said on March 26 that it will proceed to re-apply for its Greenpla, which was judged by the Korea Food and Drug Administration to be ineffective for treatment of climacteric disturbance.
Acc...
Hanmi likely to post double-digit growth
Market observers projected on March 26 that Hanmi Pharm's progress this year will fall into the double-digit territory.
“The market consensus is that boosted by robust sales of new products, including esomeprazole ...
Concerns mounting over RMS Korea
Korean Pharmaceutical firms and wholesalers need to assess the possible damage that foreign investment funds’ improper acquisition over local wholesaling firms would cause in the future and map out proper countermeasu...
Leading OTC drugmakers rushing to price hike game
Domestic OTC manufacturers are considering joining the price increase rally of their popular OTC products to cushion the impact on soaring raw material costs due to the Korean currency’s steep depreciation.
The pri...
4 human placenta supplies to be withdrawn from market
Four injectable preparations of human placenta extract will be excluded from the market due to the least efficacy, it was announced on March 26.
According to the announcement of the Korea Food and Drug Administrati...
Pharmaceutical industry struggling to find prosperity through good ethics
The Korea Pharmaceutical Manufacturers Association is aimed at promoting free and fair competition by revising the current guidelines.
Critics say the guidelines in Korea have served as measuring reference in the m...
Combined sales of 74 drugmakers top 9.3 trillion won in 2008
The combined sales of 74 Korean pharmaceutical companies and 82 pharmaceutical wholesalers last year marked 9.3 trillion won and 6.2 trillion won, respectively, according to the Korea Tax Union.
Pharmaceutical firm...
Daewoong eyes price hike of Bease
Daewoong Pharm is considering a price hike of Bease, an OTC digestive, following the expected price increase of Ursa from next month.
A spokesperson for the company said, "We are considering another price increase....
KRPIA publishes green handbook for fair competition code
The Korean Research based Pharmaceutical Industry Association (KRPIA) says it has distributed its own guidebook to its member companies in a bid to let them understand the working guideline
The KRPIA has fostered ...
